WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018009615) COMPOUNDS AND THEIR USE FOR REDUCING URIC ACID LEVELS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/009615 International Application No.: PCT/US2017/040836
Publication Date: 11.01.2018 International Filing Date: 06.07.2017
IPC:
C07D 403/12 (2006.01) ,A61K 31/501 (2006.01) ,A61K 31/541 (2006.01) ,C07D 417/12 (2006.01)
Applicants: ACQUIST LLC[US/US]; US
Inventors: PIWINSKI, John J.; US
LARIVÉE, Alexandre; CA
SIDDIQUI, Arshad; US
THAI, Karen; CA
WARRELL, Raymond P., Jr.; US
Agent: FUGIT, Donna R.; US
Priority Data:
62/358,66906.07.2016US
Title (EN) COMPOUNDS AND THEIR USE FOR REDUCING URIC ACID LEVELS
(FR) COMPOSÉS ET UTILISATION DE CES DERNIERS POUR RÉDUIRE LES NIVEAUX D'ACIDE URIQUE
Abstract: front page image
(EN) Bifunctional compounds that increase uric acid excretion and reduce uric acid production, and monofunctional compounds that either increase uric acid excretion or reduce uric acid production. Methods of using these compounds for reducing uric acid levels in blood or serum, for treating disorders of uric acid metabolism, and for maintaining normal uric acid levels in blood or serum are also provided. Pharmaceutical compositions comprising the bifunctional and monofunctional compounds are also provided.
(FR) La présente invention concerne des composés bifonctionnels qui augmentent l'excrétion d'acide urique et réduisent la production d'acide urique, et des composés monofonctionnels qui augmentent l'excrétion d'acide urique ou réduisent la production d'acide urique. L'invention concerne également des procédés d'utilisation de ces composés pour réduire des niveaux d'acide urique dans le sang ou le sérum, pour traiter des troubles du métabolisme de l'acide urique, et pour maintenir des niveaux normaux d'acide urique dans le sang ou le sérum. La présente invention concerne en outre des compositions pharmaceutiques comprenant lesdits composés bifonctionnels et monofonctionnels.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)